Gestão de Antimicrobianos

Recomendações da OMS para colaboração na resistência antimicrobiana.

8 Abr, 2022 | 21:40h

Strategic framework for collaboration on antimicrobial resistance – World Health Organization

Conteúdos relacionados:

Four priority actions to slow the silent pandemic of antimicrobial resistance.

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.

Perspective | The hidden epidemic: Antibiotic resistance is approaching a crisis point, and the world needs to act.

 

Comentário no Twitter

#DYK: Drug resistant organisms are found in people, animals, food, plants and the environment.
That's why WHO works in collaboration with @FAO, @OIEAnimalHealth & @UNEP to address #AntimicrobialResistance https://t.co/enhUb1jg2g pic.twitter.com/9elCBspx4y

— World Health Organization (WHO) (@WHO) April 6, 2022

 

---

Diretriz de consenso | Definição, diagnóstico e tratamento da mucormicose pulmonar associada a COVID-19.

6 Abr, 2022 | 12:57h

Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India – The Lancet Infectious Diseases

---

Revisão sistemática | Tempo de administração antibiótica, debridamento de feridas e estágios da cirurgia reconstrutiva para fraturas expostas de ossos longos de membros superiores e inferiores.

6 Abr, 2022 | 12:21h

Timing of antibiotic administration, wound debridement, and the stages of reconstructive surgery for open long bone fractures of the upper and lower limbs – Cochrane Library

Resumo: The timing of treatment for broken bones in the legs and arms that also have open wounds – Cochrane Library

---

Revisão | Combatendo a resistência antifúngica, uma ameaça emergente para a saúde humana.

6 Abr, 2022 | 12:11h

Tackling the emerging threat of antifungal resistance to human health – Nature Reviews Microbiology (se o acesso a este link for pago, tente este)

---

Estudo antes-e-depois | Gestão de antibióticos em pacientes com neutropenia febril de alto risco reduziu o uso de carbapenêmicos e glicopeptídios e foi associada com melhores desfechos clínicos.

5 Abr, 2022 | 11:52h

Antimicrobial stewardship in high-risk febrile neutropenia patients – Antimicrobial Resistance & Infection Control

Conteúdos relacionados:

Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile neutropenia: a single-center experience.

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines – Annals of Oncology

 

Comentário do autor no Twitter (fio – clique para saber mais)

📢 Our new study "Antimicrobial stewardship in high-risk febrile neutropenia patients." is now out in #ARIC !💥

Find our open access paper here: https://t.co/2fFoHfpEzi

And some data bellow ⬇️ (1/10) pic.twitter.com/kg4pYQs9HD

— Adrien Contejean (@AdrienContejean) March 29, 2022

 

---

Revisão sistemática | Não há evidências suficientes de que o monitoramento dos níveis séricos melhore os desfechos durante o tratamento com penicilinas.

5 Abr, 2022 | 11:51h

A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins – Journal of Antimicrobial Chemotherapy

---

Revisão sistemática | Não há evidências suficientes para apoiar ou refutar o uso de antibióticos para prevenir infecção após cirurgia para tratar incontinência urinária de esforço em mulheres.

5 Abr, 2022 | 11:37h

Prophylactic antibiotics for preventing infection after continence surgery in women with stress urinary incontinence – Cochrane Library

Resumo: Antibiotics for preventing infection following surgery to treat stress urinary incontinence in women – Cochrane Library

 

Comentário no Twitter

New review: do prophylactic antibiotics prevent infection after continence surgery in stress urinary incontinence in women? Read now via the @CochraneLibrary: https://t.co/tSIDgPU6UA pic.twitter.com/846iTjNyBH

— Cochrane Incontinence (@C_Incontinence) March 30, 2022

 

---

Uma revisão narrativa sobre a abordagem do uso de antibióticos em pacientes ventilados apresentando organismos multirresistentes em amostras respiratórias – tratar ou não tratar?

1 Abr, 2022 | 12:22h

A Narrative Review on the Approach to Antimicrobial Use in Ventilated Patients with Multidrug Resistant Organisms in Respiratory Samples—To Treat or Not to Treat? That Is the Question – Antibiotics

 

Comentário no Twitter

Important question in clinical practice
🆕💥💥Fantastic Narrative Review @antibioticsmdpi
Approach to Antimicrobial Use in Ventilated Patients with MDROs in Respiratory Samples—To Treat or Not to Treat? That Is the Question #IDTwitter #MedEd #TwitteRxhttps://t.co/aSYHr9xawv pic.twitter.com/hRjqjnZqtu

— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) March 29, 2022

 

---

Relato de caso | Os danos da antibioticoprofilaxia pós-operatória.

31 Mar, 2022 | 13:36h

The Harms of Postoperative Antibiotic Prophylaxis: A Teachable Moment – JAMA Internal Medicine (gratuito por tempo limitado)

---

Bacteriemia por S. aureus complicada e não complicada: uma pesquisa internacional Delphi entre especialistas em doenças infecciosas sobre definições e tratamento.

31 Mar, 2022 | 13:34h

Complicated and uncomplicated S. aureus bacteremia: an international Delphi survey among infectious diseases experts on definitions and treatment – Clinical Microbiology and Infection

---